Author

Zhitong Zhou

Boston UniversityORCID 0000-0002-2296-3962Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Christopher E. LietziD· 1 shared Mary DengiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christopher E. LietzORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 15, 2025

A Shared Adenocarcinoma Transcriptomic Program Enables Prediction of Therapeutics Applicable Across Tissues

Mary Deng, Zhitong Zhou, Christopher E. Lietz

This paper identifies a shared transcriptomic module across adenocarcinomas and uses it to predict FDA-approved drugs applicable to multiple cancer types.

DOI 10.1101/2025.10.15.682703

humanbulk RNA-seq

𝕏 PostBluesky